30/10/2009
ReGen Therapeutics Plc (“ReGen” or the “Company”), (AIM:RGT) is
pleased to announce that it has conditionally placed 2,500,000 new
ordinary shares at 3p per ordinary share to raise £75,000 before
expenses for general working capital purposes.
The 2,500,000 new ordinary shares, which will represent 6.81 per cent
of the enlarged issued share capital of the Company (in aggregate
amounting to 36,729,882 ordinary shares on completion of the
placing), will rank pari passu in all respects with the existing
ordinary shares in the Company.
So far this year ReGen has raised £688,185 and the fact that the
Company has been able to raise this reflects market confidence in the
Company’s ability to reach sustainable profitability in 2010.
Application has been made to the London Stock Exchange for the new
ordinary shares to be admitted to trading on AIM and admission is
expected to commence on or around Thursday, 5 November 2009.
For further information, please contact:
Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920
Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel: 020 7628 3396
David Scott/Nick Bealer
Alexander David Securities Limited
Tel: 020 7448 9820